Mohammad Hassan Bemanian
Overview
Explore the profile of Mohammad Hassan Bemanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bemanian M, Arshi S, Nabavi M, Fallahpour M, Shokri S, Sharifinejad N, et al.
Allergol Immunopathol (Madr)
. 2025 Jan;
53(1):86-90.
PMID: 39786879
Background: Hymenoptera venom allergy is a potentially severe allergic reaction in the general population. The only preventative approach in these cases is venom immunotherapy (VIT), which follows different protocols. The...
2.
Bemanian M, Shokouhi Shoormasti R, Arshi S, Jafari M, Shokri S, Fallahpour M, et al.
Allergy Asthma Clin Immunol
. 2024 Mar;
20(1):22.
PMID: 38521942
Background: The poly-sensitization to Hymenoptera venom makes it difficult to select genuine allergens for immunotherapy and increases patients' costs. The objective of this study was to determine the culprit allergen...
3.
Nazari J, Shahba F, Jafariaghdam N, Mohebbi S, Arshi S, Bemanian M, et al.
Allergy Asthma Clin Immunol
. 2024 Feb;
20(1):14.
PMID: 38360807
Background: Chronic Rhinosinusitis (CRS) is a paranasal sinus inflammatory disease and is divided into two subgroups defined as CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). CRSwNP...
4.
Taghizadeh Mortezaei N, Mohammadi S, Abolhassani H, Shokri S, Nabavi M, Fallahpour M, et al.
BMC Pediatr
. 2024 Feb;
24(1):116.
PMID: 38350907
Background: Severe combined immunodeficiencies (SCIDs) are hereditary disorders characterized by impaired T and B cell function, resulting in significant immune system dysfunction. Recombination-activating gene (RAG) mutations account for a substantial...
5.
Fazlollahi M, Hamidieh A, Moradi L, Shokouhi Shoormati R, Sabetkish N, Esmaeili B, et al.
Pediatr Allergy Immunol
. 2023 Jul;
34(7):e13990.
PMID: 37492921
Background: In order to support the comprehensive classification of Leukocyte Adhesion Deficiency-I (LAD-I) severity by simultaneous screening of CD11a/CD18, this study assessed clinical, laboratory, and genetic findings along with outcomes...
6.
Nabavi M, Arshi S, Bemanian M, Fallahpour M, Shokri S, Sabouri S, et al.
Am J Rhinol Allergy
. 2023 Feb;
37(4):384-390.
PMID: 36740870
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex disorder and effective treatment remains a major challenge. Some antibiotics with anti-inflammatory properties are reported to have potential to be...
7.
Tavakol M, Delavari S, Salami F, Ansari S, Rasouli S, Chavoshzadeh Z, et al.
Allergy Asthma Clin Immunol
. 2022 Dec;
18(1):106.
PMID: 36510326
Genetic defects in the development, maturation, and/or function of the immune cells can lead to Inborn errors of immunity (IEI) which may predispose patients to malignancies. The overall risk for...
8.
Salari F, Bemanian M, Fallahpour M, Mahdaviani S, Shokri S, Khoshmirsafa M, et al.
Clin Med Res
. 2022 Aug;
PMID: 35998948
Objective: Sesame allergy is the most prevalent allergy to seeds. Oral immunotherapy (OIT) is defined as continuous consumption of an allergen at special doses and time. Omalizumab (Anti-IgE) increases tolerance...
9.
Bahrami S, Arshi S, Nabavi M, Bemanian M, Fallahpour M, Rezaeifar A, et al.
J Med Case Rep
. 2022 Jun;
16(1):235.
PMID: 35689244
Background: Progressive multifocal leukoencephalopathy is a rare demyelinating disease that is often secondary to lytic destruction of oligodendrocytes and, to a lesser extent, to astrocytes' response to human neurotrophic John...
10.
Esmaeilzadeh H, Askarisarvestani A, Hosseini N, Samimi S, Shafiei A, Mahdaviani S, et al.
Clin Immunol
. 2021 Aug;
230:108826.
PMID: 34418548
Background: Intravenous immunoglobulins (IVIg) are the major treatment in inborn errors of immunity (IEI) disorders; However, IVIg infusions show some adverse effects. We aimed to assess the adverse reactions of...